Supply Chain Intelligence

Twist Bioscience Corporation Supply Chain

TWST supply chain intelligence for Twist Bioscience Corporation: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

TWST ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

11Suppliers
26Customers
3Debt Items
20Related Chains

Twist Bioscience Corporation Suppliers

TickerNameConfidenceEvidence
A Agilent Technologies, Inc. 72% ies, Inc., Eurofins Genomics Blue Heron, Elegen Corporation, Ansa Biotechnologies, Inc., Telesis Bio, Inc. and others. Additionally, we compete with both large and emerging providers in the life scie…
A Agilent Technologies, Inc. 72% Reciprocal relationship from A graph: Reciprocal relationship from TWST graph: ies, Inc., Eurofins Genomics Blue Heron, Elegen Corporation, Ansa Biotechnologies, Inc., Telesis Bio, Inc. and others. A…
AZTA Azenta, Inc. 72% Reciprocal relationship from AZTA graph: que portfolio of products and services. Each segment, however, has unique competitors in their area of offerings. In the Sample Management Solutions segment, …
CRL Charles River Laboratories International, Inc. 72% Reciprocal relationship from CRL graph: Reciprocal relationship from TWST graph: ies, Inc., Eurofins Genomics Blue Heron, Elegen Corporation, Ansa Biotechnologies, Inc., Telesis Bio, Inc. and others.…
CRL Charles River Laboratories International, Inc. 72% ies, Inc., Eurofins Genomics Blue Heron, Elegen Corporation, Ansa Biotechnologies, Inc., Telesis Bio, Inc. and others. Additionally, we compete with both large and emerging providers in the life scie…
IBIO iBio, Inc. 72% Reciprocal relationship from IBIO graph: Reciprocal relationship from TWST graph: Reciprocal relationship from IBIO graph: t of our agreement with them. Any of our drug candidates, therefore, may be …
SPRB Spruce Biosciences, Inc. 72% Reciprocal relationship from SPRB graph: nadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. If any of these events occurs or if we oth…
TKPHF Takeda Pharmaceutical Company Limited 72% mber 30, 2025. Some of our partners include Bayer, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Limited, Adicet Bio, Ono Pharmaceutical Ltd., Kyowa Kirin, Invetx, Inc., Astellas Pharma In…
TKPHF Takeda Pharmaceutical Company Limited 72% Reciprocal relationship from TKPHF graph: Reciprocal relationship from TWST graph: Reciprocal relationship from TKPHF graph: Reciprocal relationship from TWST graph: mber 30, 2025. Some of our partne…
TMO Thermo Fisher Scientific Inc. 72% Reciprocal relationship from TMO graph: Reciprocal relationship from TWST graph: Reciprocal relationship from TMO graph: Reciprocal relationship from TWST graph: ies, Inc., Eurofins Genomics Blue Her…
TMO Thermo Fisher Scientific Inc. 72% ies, Inc., Eurofins Genomics Blue Heron, Elegen Corporation, Ansa Biotechnologies, Inc., Telesis Bio, Inc. and others. Additionally, we compete with both large and emerging providers in the life scie…

Twist Bioscience Corporation Customers

TickerNameConfidenceEvidence
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES 95% USAspending awards from Department of Health and Human Services: $5,032,172 across 2 awards. 75N92022C00004 RADX TECH PROJECT 6818 PORTABLE, RAPID, DISPOSABLE TEST WITH SYNTHETIC ANTIBODIES FOR TESTI…
ACADEMIC-RESEARCH-AND-GOVERNMENT ACADEMIC-RESEARCH-AND-GOVERNMENT 90% both of which are primarily attributable to an increase in revenues from our customers in therapeutics, diagnostics, academic research and government industries
DIAGNOSTICS DIAGNOSTICS 90% both of which are primarily attributable to an increase in revenues from our customers in therapeutics, diagnostics, academic research and government industries
GLOBAL-SUPPLY-PARTNERS GLOBAL-SUPPLY-PARTNERS 90% both of which are primarily attributable to an increase in revenues from our customers in therapeutics, diagnostics, academic research and government and global supply partners industries
THERAPEUTICS THERAPEUTICS 90% both of which are primarily attributable to an increase in revenues from our customers in therapeutics, diagnostics, academic research and government industries
USGOV-DEPARTMENT-OF-AGRICULTURE USGOV-DEPARTMENT-OF-AGRICULTURE 90% USAspending awards from Department of Agriculture: $60,861 across 1 awards. 1232SA25P0166 TWIST 96-PLEX LIBRARY PREP KIT 10X96 SAMPLES | Qwen corrected direction: Explicit government contract relatio…
A Agilent Technologies, Inc. 72% ies, Inc., Eurofins Genomics Blue Heron, Elegen Corporation, Ansa Biotechnologies, Inc., Telesis Bio, Inc. and others. Additionally, we compete with both large and emerging providers in the life scie…
A Agilent Technologies, Inc. 72% Reciprocal relationship from A graph: Reciprocal relationship from TWST graph: ies, Inc., Eurofins Genomics Blue Heron, Elegen Corporation, Ansa Biotechnologies, Inc., Telesis Bio, Inc. and others. A…
AZTA Azenta, Inc. 72% Reciprocal relationship from AZTA graph: Reciprocal relationship from TWST graph: Reciprocal relationship from AZTA graph: que portfolio of products and services. Each segment, however, has unique co…
CRL Charles River Laboratories International, Inc. 72% ies, Inc., Eurofins Genomics Blue Heron, Elegen Corporation, Ansa Biotechnologies, Inc., Telesis Bio, Inc. and others. Additionally, we compete with both large and emerging providers in the life scie…
CRL Charles River Laboratories International, Inc. 72% Reciprocal relationship from CRL graph: Reciprocal relationship from TWST graph: ies, Inc., Eurofins Genomics Blue Heron, Elegen Corporation, Ansa Biotechnologies, Inc., Telesis Bio, Inc. and others.…
GRAL GRAIL, Inc. 72% Reciprocal relationship from GRAL graph: Reciprocal relationship from TWST graph: Reciprocal relationship from GRAL graph: Reciprocal relationship from TWST graph: Reciprocal relationship from GRAL g…
IBIO iBio, Inc. 72% Reciprocal relationship from IBIO graph: as well as enhancements to our existing offerings, both of which are necessary to maintain our competitive position. Our research and development activities t…
SPRB Spruce Biosciences, Inc. 72% Reciprocal relationship from SPRB graph: and time-consuming, and the outcome is unpredictable. Even though we use commonly accepted security measures, the criteria for protection of trade secrets can…
TKPHF Takeda Pharmaceutical Company Limited 72% Reciprocal relationship from TKPHF graph: Reciprocal relationship from TWST graph: mber 30, 2025. Some of our partners include Bayer, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Limited,…
TKPHF Takeda Pharmaceutical Company Limited 72% mber 30, 2025. Some of our partners include Bayer, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Limited, Adicet Bio, Ono Pharmaceutical Ltd., Kyowa Kirin, Invetx, Inc., Astellas Pharma In…
TMO Thermo Fisher Scientific Inc. 72% ies, Inc., Eurofins Genomics Blue Heron, Elegen Corporation, Ansa Biotechnologies, Inc., Telesis Bio, Inc. and others. Additionally, we compete with both large and emerging providers in the life scie…
TMO Thermo Fisher Scientific Inc. 72% Reciprocal relationship from TMO graph: Reciprocal relationship from TWST graph: ies, Inc., Eurofins Genomics Blue Heron, Elegen Corporation, Ansa Biotechnologies, Inc., Telesis Bio, Inc. and others.…
ABCELLERA-BIOLOGICS-INC ABCELLERA-BIOLOGICS-INC 62% ns including Curia, GenScript, and Genovac (formerly part of Aldevron, LLC), and antibody discovery biotechnology companies, such as Fair Journey/Iontas, Adimab, Distributed Bio (owned by Charles Riv…
ABX-BIOLOGICS-INC ABX-BIOLOGICS-INC 62% able of Contents Year ended September 30, (in thousands) 2024 2023 2022 Synthetic genes $ 92,679 $ 73,541 $ 61,509 Oligo pools 16,906 14,489 12,424 DNA libraries 13,933 10,201 6,149 Antibody discover…
ALDEVRON-LLC ALDEVRON-LLC 62% ns including Curia, GenScript, and Genovac (formerly part of Aldevron, LLC), and antibody discovery biotechnology companies, such as Fair Journey/Iontas, Adimab, Distributed Bio (owned by Charles Riv…
BIOMEMORY-CATALOG-TECHNOLOGIES-INC BIOMEMORY-CATALOG-TECHNOLOGIES-INC 62% a storage, we compete with Biomemory, Catalog Technologies, Inc., GenScript, various academic institutions, and other emerging competitors. We may not be successful in maintaining our competitive pos…
GENSCRIPT-BIOTECH-CORPORATION-DNA-SCRIPT-INC GENSCRIPT-BIOTECH-CORPORATION-DNA-SCRIPT-INC 62% , and the negotiation process is time-consuming and complex. Any new collaboration may be on terms that are not optimal for us, and we may not be able to maintain any new collaboration. Any such coll…
INC-INTEGRATED-DNA-TECHNOLOGIES-INC INC-INTEGRATED-DNA-TECHNOLOGIES-INC 62% na, Inc., Integrated DNA Technologies, Inc., Roche, New England Bioloabs and Agilent. In the antibody discovery market, we compete with contract research organizations including Curia, GenScript, and…
ORIGENE-TECHNOLOGIES-INC-BLUE-HERON-BIOTECH-LLC ORIGENE-TECHNOLOGIES-INC-BLUE-HERON-BIOTECH-LLC 62% , and the negotiation process is time-consuming and complex. Any new collaboration may be on terms that are not optimal for us, and we may not be able to maintain any new collaboration. Any such coll…
THERMO-FISHER-SCIENTIFIC-INC-ILLUMINA-INC-INTEGR THERMO-FISHER-SCIENTIFIC-INC-ILLUMINA-INC-INTEGR 62% , and the negotiation process is time-consuming and complex. Any new collaboration may be on terms that are not optimal for us, and we may not be able to maintain any new collaboration. Any such coll…

Twist Bioscience Corporation Debt Obligations

InstrumentDescriptionConfidenceEvidence
TWST-DEBT-13172 Warrants outstanding: 7531 90% xbrl warrant detail from xbrl 2020-11-30.
TWST-DEBT Debt stack $110.8M 90% Market cache reports total debt of $110.8M.
TWST-DEBT-13173 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-09-30.

Twist Bioscience Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Twist Bioscience Corporation.

Twist Bioscience Corporation Ownership

HolderNameConfidenceEvidence
TWST-OWNER-ARTISAN-PARTNERS-LIMITED-PARTNER Artisan Partners Limited Partnership 90% 13F overlay lists Artisan Partners Limited Partnership as top holder; 285 tracked holders.

Twist Bioscience Corporation Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
IMTX Immatics N.V. 100.00 2
IDXG Interpace Biosciences, Inc. 100.00 2
GILD Gilead Sciences, Inc. 100.00 2
GDTC CytoMed Therapeutics Limited 100.00 2
ICLR ICON Public Limited Company 100.00 2
GH Guardant Health, Inc. 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
CLLS Cellectis S.A. 100.00 2
BMYMP Bristol-Myers Squibb Co 100.00 2
CRL Charles River Laboratories International, Inc. 100.00 1 ['customer', 'supplier']
BNR Burning Rock Biotech Limited 100.00 2
BHPLF BHP Group Limited 100.00 2
CLDX Celldex Therapeutics, Inc. 100.00 2
EXAS Exact Sciences Corp 100.00 2
CRSP CRISPR Therapeutics AG 100.00 2
A Agilent Technologies, Inc. 100.00 1 ['customer', 'supplier']
ABT Abbott Laboratories 100.00 2
BTAI BioXcel Therapeutics, Inc. 100.00 2
BMY Bristol-Myers Squibb Company 100.00 2
TEM Tempus AI, Inc. 100.00 2
View TWST supply chain intel →

Explore the full interactive supply chain map for Twist Bioscience Corporation.

Open TWST supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map